The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

February is American Heart Month -- a time dedicated to raising awareness about heart disease, the leading cause of death in ...

While common risk factors like high blood pressure, high cholesterol, obesity and smoking are well-known, there are other ...

Guthrie officials said that cardiovascular diseases are the leading killer in the United States, but there are steps that ...

February is the month of love, and local cardiologists want you to show your heart some love this month with some simple, heart healthy habits.

Heart disease claims more lives in America than any other medical problem every year, therefore keeping your heart and ...

The Go Red for Women Luncheon was held in Hampton at the Hampton Roads Convention Center, on a very appropriate date this ...

From menopause to stress, here is everything Black women need to know about living with and preventing heart disease.

Long-time volunteer at Northwestern Medicine Delnor Hospital in Geneva celebrates procedure that saved her heart as hospital ...

The event emphasized the critical role of primary care physicians in staying informed about innovative approaches to prevent ...

Cardiovascular diseases claim more lives in the U.S. than all forms of cancer and accidental deaths combined, according to ...